Cart
sales@molnova.com
Epertinib hydrochloride
CAS No. 2071195-74-7
Epertinib hydrochloride ( S-22611 hydrochloride )
Catalog No. M23929 CAS No. 2071195-74-7
Epertinib hydrochloride shows potent antitumor activity.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 129 | In Stock |
|
| 5MG | 222 | In Stock |
|
| 10MG | 356 | In Stock |
|
| 25MG | 601 | In Stock |
|
| 50MG | 858 | In Stock |
|
| 100MG | 1161 | In Stock |
|
| 500MG | 2331 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEpertinib hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpertinib hydrochloride shows potent antitumor activity.?
-
DescriptionEpertinib hydrochloride shows potent antitumor activity.?Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively.
-
SynonymsS-22611 hydrochloride
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR;HER4;HER2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2071195-74-7
-
Formula Weight596.5
-
Molecular FormulaC30H28Cl2FN5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (209.56 mM; Need ultrasonic)
-
SMILESCC#C/C(=N\OC[C@H]1COCCN1)/C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tanaka H, et al. Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2. Cancer Sci. 2014 Aug;105(8):1040-8.
molnova catalog
related products
-
AG-1557 hydrochlorid...
AG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
CP-380736
CP-380736 is an epidermal growth factor receptor (EGFR) inhibitor. EGFR is a tyrosine kinase that activates MAPK, JNK, and Akt pathways, and is an important mediator of several types of cancer.
-
Epertinib
Epertinib (S-222611) is a novel potent, orally active, reversible EGFR and HER2 inhibitor with IC50 of 1.48, 7.15 and 2.49 nM for EGFR, HER2 and HER4, respectively.
